Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976;292(2):133-6.
doi: 10.1007/BF00498583.

Recovery of dopamine in peripheral adrenergic nerves after reserpine treatment

Recovery of dopamine in peripheral adrenergic nerves after reserpine treatment

O Almgren et al. Naunyn Schmiedebergs Arch Pharmacol. 1976.

Abstract

The endogenous levels of dopamine (DA) in the rat heart and submaxillary gland after a single, large dose of reserpine (10 mg/kg i.p.) were reduced to near zero within 1 h and were restored to normal within 48 h, while the noradrenaline (NA) levels reacted much more slowly. The data suggest that newly formed DA is rapidly taken up by the reserpinesensitive mechanism of the amine storage granules. The more rapid restoration of DA than of NA levels may be due to preferential release of newly formed NA by the nerve impulse. Electrical stimulation of the cervical sympathetic with 5 Hz for 30 min 4 h after the administration of reserpine increased the DA level of the submaxillary gland of the stimulated side, suggesting an increased tyrosine hydroxylase activity during stimulation, also in nerve terminals affected by reserpine. The use of an inhibitor of monoamine oxidase (pargyline) and/or an inhibitor of dopamine beta-hydroxylase (FLA-63) did not significantly alter the increase of DA following nerve stimulation, suggesting DA was protected by granular uptake. The stimulation-induced increase in DA was, however, much less in reserpine-treated than in normal animals, demonstrating the importance of the reserpine-sensitive uptake mechanisms for preserving newly formed DA.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Acta Physiol Scand. 1966 Jul-Aug;67(3):423-9 - PubMed
    1. Br J Pharmacol. 1973 Aug;48(4):699-714 - PubMed
    1. J Pharm Pharmacol. 1971 Sep;23(9):671-7 - PubMed
    1. Acta Physiol Scand. 1971 Dec;83(4):515-26 - PubMed
    1. Br J Pharmacol. 1973 Sep;49(1):141P-142P - PubMed